Proven results with COBENFY™

(xanomeline and trospium chloride)

Actor portrayal.

COBENFY improved schizophrenia symptoms

Studied in three 5-week and two 52-week clinical studies with more than 1250 adults with schizophrenia.

In 2 clinical studies,* COBENFY showed...

Icon

Proven significant symptom relief vs placebo (sugar pill)

Icon

Overall improvement across a range of symptoms*

A infographic defining positive and negative symptoms
* A schizophrenia rating scale was used to compare meaningful changes in symptoms overall. These symptoms included positive, negative, and general psychopathology symptoms.

In 1 clinical study, COBENFY...

Icon

Reduced the overall severity of schizophrenia

A different schizophrenia rating tool was used to evaluate meaningful overall changes in the severity of schizophrenia.

COBENFY was studied in two 5-week clinical studies with 470 adults aged 18 to 65 diagnosed with schizophrenia. Participants either took COBENFY or a sugar pill.

Individual results may vary.

Chayilee is paid by BMS and not on COBENFY.

Start the conversation with your healthcare provider

Check out the COBENFY Discussion Guide for a personalized checklist to bring up at your next appointment.

Actor portrayals.

Jia and Kelsey are paid by BMS and Kelsey is not on COBENFY.



Cobenfy, Cobenfy Cares, and the Cobenfy logo are trademarks of Karuna Therapeutics, Inc., a Bristol Myers Squibb company.
© 2025 Bristol-Myers Squibb Company. 
1629-US-2500035 03/25
This website is intended for U.S. residents 18 years of age or older.